Clinical Trial Update: Pioglitazone on Cardiac Function and Large Arteries (PICCOLA Study) [Phase 4]

View source ↗

Summary

The PICCOLA study, a Phase 4 trial evaluating pioglitazone on cardiac function and large-artery health in diabetes, has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• PIOGLITAZONE (Pioglitazone)

Snippet

Sponsor: Imperial College London | Conditions: Diabetes | Phase 4 | Status: COMPLETED